Amicus Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Amicus Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Amicus Therapeutics Inc Strategy Report
- Understand Amicus Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Amicus Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP3675853B1 | Grant | VERFAHREN ZUR VERSTÄRKUNG UND/ODER STABILISIERUNG DER HERZFUNKTION IN PATIENTEN MIT MORBUS FABRY | A61K31/445; A61K9/08; A61K9/20; A61K9/48; A61P43/00; A61P9/00; A61P9/04 | September 07, 2022 |
AR122298A1 | Application | MÉTODOS PARA TRATAR LA ENFERMEDAD DE FABRY EN PACIENTES QUE TIENEN UNA MUTACIÓN EN EL GEN GLA | August 31, 2022 | |
AR122260A1 | Application | COMPOSICIONES ÚTILES PARA EL TRATAMIENTO DE LA ENFERMEDAD DE POMPE | August 31, 2022 | |
SI3436053T1 | Grant | FORMULATIONS COMPRISING RECOMBINANT ACID ALPHA-GLUCOSIDASE | A61K38/47; C12N9/2408; C12Y302/0102 | August 31, 2022 |
ES2921673T3 | Grant | Formulaciones que contienen alfa-glucosidasa ácida recombinante | A61K38/47; C12N9/2408; C12Y302/0102 | August 30, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer